FGFR-2 protein has been reported to be over-expressed in NSCLC [26], while FGFR inhibition has recently been shown to block lung cancer growth both in-vitro and in-vivo [27, 28]. The gene discussed is FGFR2; the disease is non-small cell lung carcinoma.